, a bio/informatics shared resource is still "open for business" - Visit the CDS website


  1. Factors predicting future ACS episodes in children with sickle cell anemia. DeBaun MR, Rodeghier M, Cohen R, Kirkham FJ, Rosen CL, Roberts I, Cooper B, Stocks J, Wilkey O, Inusa B, Warner JO, Strunk RC (2014) Am J Hematol 89(11): E212-7
    › Citation · 25088663 (PubMed) · PMC4866602 (PubMed Central)
  2. Controlled trial of transfusions for silent cerebral infarcts in sickle cell anemia. DeBaun MR, Gordon M, McKinstry RC, Noetzel MJ, White DA, Sarnaik SA, Meier ER, Howard TH, Majumdar S, Inusa BP, Telfer PT, Kirby-Allen M, McCavit TL, Kamdem A, Airewele G, Woods GM, Berman B, Panepinto JA, Fuh BR, Kwiatkowski JL, King AA, Fixler JM, Rhodes MM, Thompson AA, Heiny ME, Redding-Lallinger RC, Kirkham FJ, Dixon N, Gonzalez CE, Kalinyak KA, Quinn CT, Strouse JJ, Miller JP, Lehmann H, Kraut MA, Ball WS, Hirtz D, Casella JF (2014) N Engl J Med 371(8): 699-710
    › Citation · 25140956 (PubMed) · PMC4195437 (PubMed Central)
  3. Thrombospondin-1 and L-selectin are associated with silent cerebral infarct in children with sickle cell anaemia. Faulcon LM, Fu Z, Dulloor P, Barron-Casella E, Savage W, Jennings JM, Van Eyk JE, Debaun M, Casella JF, Everett A (2013) Br J Haematol 162(3): 421-4
    › Citation · 23672305 (PubMed) · PMC4391368 (PubMed Central)
  4. Sickle hemoglobin disturbs normal coupling among erythrocyte O2 content, glycolysis, and antioxidant capacity. Rogers SC, Ross JG, d'Avignon A, Gibbons LB, Gazit V, Hassan MN, McLaughlin D, Griffin S, Neumayr T, Debaun M, DeBaun MR, Doctor A (2013) Blood 121(9): 1651-62
    › Citation · 23297128 (PubMed) · PMC3587328 (PubMed Central)
  5. Sickle cell disease, vasculopathy, and therapeutics. Kassim AA, DeBaun MR (2013) Annu Rev Med : 451-66
    › Citation · 23190149 (PubMed)
  6. Pediatric stroke, health disparities, and biological differences in disease pathophysiology. Jordan LC, DeBaun MR (2013) JAMA Pediatr 167(8): 695-7
    › Citation · 23797783 (PubMed)
  7. Exploring barriers and facilitators to clinical trial enrollment in the context of sickle cell anemia and hydroxyurea. Lebensburger JD, Sidonio RF, Debaun MR, Safford MM, Howard TH, Scarinci IC (2013) Pediatr Blood Cancer 60(8): 1333-7
    › Citation · 23418000 (PubMed) · PMC5319435 (PubMed Central)
  8. Environmental tobacco smoke and airway obstruction in children with sickle cell anemia. Cohen RT, Strunk RC, Field JJ, Rosen CL, Kirkham FJ, Redline S, Stocks J, Rodeghier MJ, DeBaun MR (2013) Chest 144(4): 1323-1329
    › Citation · 23681054 (PubMed) · PMC3787918 (PubMed Central)
  9. Emergency provider analgesic practices and attitudes toward patients with sickle cell disease. Glassberg JA, Tanabe P, Chow A, Harper K, Haywood C, DeBaun MR, Richardson LD (2013) Ann Emerg Med 62(4): 293-302.e10
    › Citation · 23561465 (PubMed) · PMC3800083 (PubMed Central)
  10. Association between baseline fetal hemoglobin levels and incidence of severe vaso-occlusive pain episodes in children with sickle cell anemia. Bhatnagar P, Keefer JR, Casella JF, Barron-Casella EA, Bean CJ, Hooper CW, Payne AB, Arking DE, Debaun MR (2013) Pediatr Blood Cancer 60(10): E125-7
    › Citation · 23677903 (PubMed) · PMC4387562 (PubMed Central)